195 related articles for article (PubMed ID: 38196574)
21. Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from Coxsackievirus B3-induced myocarditis.
Yao HL; Song J; Sun P; Song QQ; Sheng LJ; Chi MM; Han J
Virus Res; 2016 Feb; 213():314-321. PubMed ID: 26779987
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
23. Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice.
Xue Y; Chen M; Chen Q; Huang T; Fan Q; Lin F; Ke J; Chen F
Virol J; 2021 Nov; 18(1):220. PubMed ID: 34775963
[TBL] [Abstract][Full Text] [Related]
24. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d.
Huber SA
Med Microbiol Immunol; 2005 May; 194(3):121-7. PubMed ID: 15107990
[TBL] [Abstract][Full Text] [Related]
25. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis.
Ho HT; Peischard S; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2021 Nov; 55(6):679-703. PubMed ID: 34791861
[TBL] [Abstract][Full Text] [Related]
26. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
Shi Y; Chen C; Lisewski U; Wrackmeyer U; Radke M; Westermann D; Sauter M; Tschöpe C; Poller W; Klingel K; Gotthardt M
J Am Coll Cardiol; 2009 Apr; 53(14):1219-26. PubMed ID: 19341864
[TBL] [Abstract][Full Text] [Related]
27. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
28. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
29. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
[TBL] [Abstract][Full Text] [Related]
30. Sex-specific signaling through Toll-Like Receptors 2 and 4 contributes to survival outcome of Coxsackievirus B3 infection in C57Bl/6 mice.
Roberts BJ; Dragon JA; Moussawi M; Huber SA
Biol Sex Differ; 2012 Dec; 3(1):25. PubMed ID: 23241283
[TBL] [Abstract][Full Text] [Related]
31. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis.
Kim SH; Shin HH; Kim JH; Park JH; Jeon ES; Lim BK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163412
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
33. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
34. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.
Coronado MJ; Brandt JE; Kim E; Bucek A; Bedja D; Abston ED; Shin J; Gabrielson KL; Mitzner W; Fairweather D
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1726-36. PubMed ID: 22328081
[TBL] [Abstract][Full Text] [Related]
35. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.
Meyer IS; Goetzke CC; Kespohl M; Sauter M; Heuser A; Eckstein V; Vornlocher HP; Anderson DG; Haas J; Meder B; Katus HA; Klingel K; Beling A; Leuschner F
Front Immunol; 2018; 9():2303. PubMed ID: 30349538
[TBL] [Abstract][Full Text] [Related]
36. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection.
Hanson PJ; Hossain AR; Qiu Y; Zhang HM; Zhao G; Li C; Lin V; Sulaimon S; Vlok M; Fung G; Chen VH; Jan E; McManus BM; Granville DJ; Yang D
Front Cell Infect Microbiol; 2019; 9():265. PubMed ID: 31396490
[TBL] [Abstract][Full Text] [Related]
37. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo.
Riad A; Westermann D; Escher F; Becher PM; Savvatis K; Lettau O; Heimesaat MM; Bereswill S; Volk HD; Schultheiss HP; Tschöpe C
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2024-31. PubMed ID: 20228254
[TBL] [Abstract][Full Text] [Related]
38. TRIM18 is a critical regulator of viral myocarditis and organ inflammation.
Fang M; Zhang A; Du Y; Lu W; Wang J; Minze LJ; Cox TC; Li XC; Xing J; Zhang Z
J Biomed Sci; 2022 Jul; 29(1):55. PubMed ID: 35909127
[TBL] [Abstract][Full Text] [Related]
39. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
40. Antiviral and myocyte protective effects of IL-28A in coxsackievirus B3-induced myocarditis.
Wang S; Huang X; Zhang J; Huang C
Braz J Infect Dis; 2015; 19(2):132-40. PubMed ID: 25528576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
